Editas Medicine, Inc. Financial Ratios — EDIT Stock

Profitability (USD)

	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
Return on Common Equity (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Return on Assets (%)	- -	-186.58	-90.25	-51.35	-39.95	-27.71	-28.79	-21.45	-30.8	-36.99	-30.24	-56.4	-60.61
Return on Capital (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Return on Invested Capital (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Gross Margin (%)	- -	- -	100	100	100	100	100	100	100	100	100	100	100
EBITDA Margin (%)	- -	- -	-2,138.8	-1,585.76	-854.09	-345.91	-672.6	-144.25	-736.35	-1,114.11	-208.8	-721.39	-232.13
Operating Margin (%)	- -	- -	-2,167.71	-1,605.62	-873.64	-356.1	-686.39	-148.61	-756.13	-1,146.26	-216.56	-739.37	-245.15
Incremental Operating Margin (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Pretax Margin (%)	- -	- -	-4,475.14	-1,605.53	-876.49	-344.28	-651.43	-127.82	-753.61	-1,118.26	-196.13	-733.72	-395.01
Profit Margin (%)	- -	- -	-4,475.14	-1,605.53	-876.49	-344.28	-651.43	-127.82	-753.61	-1,118.26	-196.13	-733.72	-395.01
Net Income to Common Margin (%)	- -	- -	-4,499.32	-1,606.31	-876.49	-344.28	-651.43	-127.82	-753.61	-1,118.26	-196.13	-733.72	-395.01
Effective Tax Rate (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Dvd Payout Ratio (%)	- -	-7.34	0.54	0.05	- -	- -	- -	- -	- -	- -	- -	- -	- -
Sustainable Growth Rate (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -

Credit (USD)

API Chat

	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
Total Debt	2	- -	200	45	41	32	29	26	26	44	37	35	18
ST Debt	- -	- -	- -	10	8	- -	6	7	10	11	12	15	6
LT Debt	2	- -	200	35	33	32	23	19	16	33	24	20	12
Total Debt/EBITDA	- -	-0.03	-5.74	-0.47	-0.35	-0.29	-0.21	-0.2	-0.14	-0.2	-0.22	-0.15	-0.19
Net Debt/EBITDA	- -	0.81	-1.63	1.83	1.19	1.22	1.72	1.07	1.08	0.64	0.76	0.56	1.56
Total Debt/EBIT	- -	-0.03	-5.66	-0.46	-0.34	-0.29	-0.21	-0.19	-0.14	-0.19	-0.22	-0.15	-0.18
Net Debt/EBIT	- -	0.8	-1.61	1.8	1.16	1.19	1.69	1.04	1.05	0.63	0.73	0.55	1.48
EBITDA to Interest Expense	- -	-369.59	-243.64	1,548.16	-119.89	32.07	18.88	- -	- -	- -	- -	-106.44	-15.24
EBITDA-CapEx/Interest Expense	- -	-405.38	-253.65	1,604.5	-121.99	33.45	19.73	- -	- -	- -	- -	-110.47	-15.34
EBIT to Interest Expense	- -	-374.21	-246.94	1,567.55	-122.63	33.01	19.27	- -	- -	- -	- -	-109.1	-16.1
Interest Expense	- -	- -	- -	- -	1	-3	-7	- -	- -	- -	- -	2	6
Common Equity/Total Assets	-71.06	-126.75	-59.15	-80.95	-81.94	-99.02	-107.93	-116.17	-126.6	-209.62	-246.69	-429.88	-873.03
Long-Term Debt/Equity (%)	- -	- -	- -	26.07	16.07	13.73	8.87	4.91	2.9	9.11	6.98	15.18	44.24
Long-Term Debt/Capital (%)	606.61	-2.29	179.19	-24.99	-12.62	-8.45	-4.48	-3.02	-1.93	-3.18	-2.04	-1.42	-0.75
Long-Term Debt/Total Assets (%)	85.09	2.82	133.85	15.31	8.96	7.71	4.57	3.37	2.37	6.39	4.88	5.97	6.47
Total Debt/Equity (%)	-119.74	-2.69	-240.53	33.5	19.67	13.73	11.08	6.64	4.76	12.18	10.47	26.09	66.34
Total Debt/Capital (%)	606.61	-2.73	179.19	-32.11	-15.45	-8.45	-5.59	-4.09	-3.17	-4.25	-3.06	-2.44	-1.12
Total Debt/Total Assets (%)	85.09	3.37	133.85	19.68	10.97	7.71	5.71	4.56	3.89	8.54	7.32	10.26	9.7
Net Debt to Equity	-5.62	66.78	-68.26	-130.25	-66.86	-57.07	-90.76	-35.49	-36.76	-39.24	-35.42	-97.96	-537.4
Net Debt/Capital (%)	-5.95	39.8	-179.47	53.82	33.81	25.99	31.41	17.94	19.67	12.04	9.38	8.41	8.35
EBITDA	- -	-13	-35	-96	-117	-110	-138	-131	-188	-220	-163	-233	-94
EBITDA-CapEx	- -	-14	-36	-99	-119	-115	-144	-138	-196	-224	-168	-242	-95
Operating Income (Loss)	- -	-13	-35	-97	-120	-114	-141	-135	-193	-226	-169	-239	-99

Liquidity (USD)

API Chat

	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
Cash Ratio	0.95	1.72	20.68	5.6	8.97	10.28	7.62	6.91	10.66	5.73	5.11	3.5	3.17
Current Ratio	0.98	1.74	20.94	5.66	9.05	10.44	7.74	7.2	10.82	5.94	5.39	3.75	3.54
Quick Ratio	0.95	1.72	20.82	5.6	8.99	10.28	7.63	7.01	10.67	5.81	5.27	3.71	3.5
CFO/Avg Current Liab	- -	-2.09	-0.83	-2.51	-0.27	-1.26	-0.85	-3.04	-3.12	-3.32	-2.14	-2.99	-2.68
Common Equity/Total Assets	-71.06	-126.75	-59.15	-80.95	-81.94	-99.02	-107.93	-116.17	-126.6	-209.62	-246.69	-429.88	-873.03
Long-Term Debt/Equity (%)	- -	- -	- -	26.07	16.07	13.73	8.87	4.91	2.9	9.11	6.98	15.18	44.24
Long-Term Debt/Capital (%)	606.61	-2.29	179.19	-24.99	-12.62	-8.45	-4.48	-3.02	-1.93	-3.18	-2.04	-1.42	-0.75
Long-Term Debt/Total Assets (%)	85.09	2.82	133.85	15.31	8.96	7.71	4.57	3.37	2.37	6.39	4.88	5.97	6.47
Total Debt/Equity (%)	-119.74	-2.69	-240.53	33.5	19.67	13.73	11.08	6.64	4.76	12.18	10.47	26.09	66.34
Total Debt/Capital (%)	606.61	-2.73	179.19	-32.11	-15.45	-8.45	-5.59	-4.09	-3.17	-4.25	-3.06	-2.44	-1.12
Total Debt/Total Assets (%)	85.09	3.37	133.85	19.68	10.97	7.71	5.71	4.56	3.89	8.54	7.32	10.26	9.7
CFO/Total Liabilities	- -	-31.5	-2.34	-53.13	-5.7	-24.81	-16.5	-100.46	-132.27	-115.43	-88.09	-101.43	-103.76
CFO/CapEx	- -	-7.11	-3.8	-14.38	-4.57	-9.61	-6.59	-25.11	-20.53	-43.07	-28.01	-23.83	-272.23
Altman's Z-Score	-1.01	-4.77	-0.49	1.62	3.28	2.25	2.17	12.28	6.84	-1.28	-0.67	-7.18	-13.01

Working Capital (USD)

API Chat

	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
Accounts Receivable Turnover	- -	- -	3.2	10.94	35.8	90.09	91.66	28.06	8.09	7.28	10.19	2.44	2.58
Days Sales Outstanding	- -	- -	114.16	33.38	10.2	4.05	3.98	13.01	45.12	50.11	35.82	149.4	141.61
Inventory Turnover	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Days Inventory Outstanding	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Accounts Payable Turnover	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Accounts Payable Turnover Days	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Cash Conversion Cycle	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Inventory to Cash Days	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Inventories	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Raw Materials	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Work In Process	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Finished Goods	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Other Inventory	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -

Enterprise Value (USD)

API Chat

	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
Market Capitalization	- -	- -	- -	523	1,239	1,071	1,480	4,109	1,795	609	770	105	- -
- Cash & Cash Equivalents	2	11	143	185	147	135	238	140	204	142	124	132	147
+ Preferred Equity and Hybrid Capital	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Minority/Non Controlling Interest	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Total Debt	2	- -	200	45	41	32	29	26	26	44	37	35	18
Enterprise Value	- -	-10	57	383	951	735	1,052	3,733	1,322	309	483	-130	-129
Total Capital	- -	-15	112	-140	-265	-384	-520	-639	-831	-1,034	-1,195	-1,433	-1,610
Total Debt/Capital (%)	606.61	-2.73	179.19	-32.11	-15.45	-8.45	-5.59	-4.09	-3.17	-4.25	-3.06	-2.44	-1.12
Total Debt / EV	21.32	-0.04	3.52	0.12	0.04	0.04	0.03	0.01	0.02	0.14	0.08	-0.27	-0.14
EV/Sales	- -	- -	34.83	63.22	69.27	23.01	51.24	41.14	51.75	15.66	6.18	- -	- -
EV/EBITDA	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
EV/EBIT	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
EV/Cash Flow to Firm	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
EV/Free Cash Flow to Firm	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Diluted Market Cap	- -	- -	- -	523	1,239	1,071	1,480	4,109	1,795	609	770	105	- -
Diluted Enterprise Value	- -	-10	57	383	1,133	969	1,271	3,996	1,618	511	682	8	-129
EV per Share	- -	- -	1.59	11.88	23.58	15.6	21.05	63.7	19.55	4.5	6.36	- -	- -
TTM Sales	- -	- -	2	6	14	32	21	91	26	20	78	32	41
TTM EBITDA	- -	-13	-35	-96	-117	-110	-138	-131	-188	-220	-163	-233	-94
TTM Operating Income	- -	-13	-35	-97	-120	-114	-141	-135	-193	-226	-169	-239	-99
TTM Cash Flow to Firm	- -	-9	-5	-50	-8	-49	-48	-180	-164	-177	-132	-208	-159
TTM Free Cash Flow to Firm	- -	-7	-4	-47	-6	-44	-42	-173	-156	-173	-127	-199	-158

Multiples (USD)

API Chat

	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
Price/Free Cash Flow	- -	- -	- -	-11.18	-168.41	-26.16	-42.9	-23.8	-11.52	-3.52	-6.04	-0.52	- -
EV/EBIT	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Enterprise Value	- -	-10	57	383	951	735	1,052	3,733	1,322	309	483	-130	-129
Low Price	- -	- -	- -	12.43	13.12	17.8	19	14.01	26.51	8.21	6.08	1.16	0.91
EV/Sales	- -	- -	34.83	63.22	69.27	23.01	51.24	41.14	51.75	15.66	6.18	- -	- -
EV/EBITDA	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Price/Earnings	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Price/Earnings Average	- -	- -	- -	-7.86	-6.95	-13.98	-9	-15.83	-16.05	-4.56	-4.33	-1.8	- -
Price/Earnings High	- -	- -	- -	-14.58	-11.01	-19.28	-12.27	-48.74	-35.11	-8.72	-5.91	-4.02	- -
Price/Earnings Low	- -	- -	- -	-4.12	-4.4	-7.62	-7.1	-7.08	-9.31	-2.56	-3.01	-0.4	- -
Price/Book Value	- -	- -	- -	-2.82	-4.05	-2.57	-2.69	-6.18	-2.09	-0.56	-0.62	-0.07	- -
Price/Book Value Average	- -	- -	- -	-4.12	-2.73	-3.69	-2.19	-2.76	-3.6	-0.93	-0.54	-0.29	- -
Price/Book Value High	- -	- -	- -	-7.64	-4.33	-5.09	-2.99	-8.5	-7.88	-1.78	-0.74	-0.65	- -
Price/Book Value Low	- -	- -	- -	-2.16	-1.73	-2.01	-1.73	-1.23	-2.09	-0.52	-0.38	-0.07	- -
Price/Tangible Book Value	- -	- -	- -	3.88	5.96	4.54	5.64	10.44	3.24	1.69	2.2	0.78	- -
Price/Tangible Book Value Average	- -	- -	- -	5.68	4.02	6.51	4.59	4.66	5.58	2.79	1.9	3.17	- -
Price/Tangible Book Value High	- -	- -	- -	10.53	6.37	8.98	6.25	14.36	12.21	5.33	2.6	7.1	- -
Price/Tangible Book Value Low	- -	- -	- -	2.98	2.54	3.55	3.62	2.09	3.24	1.56	1.32	0.71	- -
Price/Sales	- -	- -	- -	86.39	90.26	33.55	72.09	45.29	70.28	30.9	9.85	3.24	- -
Price/Sales Average	- -	- -	- -	126.22	60.92	48.12	58.62	20.23	120.93	50.96	8.5	13.18	- -
Price/Sales High	- -	- -	- -	234.16	96.49	66.39	79.9	62.3	264.58	97.5	11.6	29.51	- -
Price/Sales Low	- -	- -	- -	66.16	38.54	26.25	46.26	9.05	70.18	28.59	5.91	2.96	- -
Price/Cash Flow	- -	- -	- -	-10.41	-131.59	-23.44	-36.39	-22.85	-10.96	-3.43	-5.82	-0.5	- -
Price/Cash Flow Average	- -	- -	- -	-15.21	-88.81	-33.62	-29.59	-10.21	-18.86	-5.66	-5.02	-2.03	- -
Price/Cash Flow High	- -	- -	- -	-28.21	-140.66	-46.39	-40.34	-31.43	-41.26	-10.84	-6.85	-4.53	- -
Price/Cash Flow Low	- -	- -	- -	-7.97	-56.18	-18.34	-23.35	-4.57	-10.94	-3.18	-3.49	-0.45	- -
Price/Free Cash Flow Average	- -	- -	- -	-16.34	-113.66	-37.53	-34.88	-10.63	-19.82	-5.8	-5.21	-2.11	- -
Price/Free Cash Flow High	- -	- -	- -	-30.32	-180.03	-51.77	-47.55	-32.74	-43.37	-11.09	-7.11	-4.73	- -
Price/Free Cash Flow Low	- -	- -	- -	-8.57	-71.9	-20.47	-27.53	-4.76	-11.5	-3.25	-3.62	-0.47	- -
EV/Sales Average	- -	- -	34.83	103.05	53.22	44.91	48.44	18.98	113.99	46.01	7.38	10.2	- -
EV/Sales High	- -	- -	34.83	210.99	88.79	63.19	69.72	61.05	257.65	92.55	10.48	26.52	- -
EV/Sales Low	- -	- -	34.83	43	30.84	23.04	36.07	7.8	63.24	23.64	4.8	- -	- -
EV/EBITDA Average	- -	0.81	-1.63	-6.5	-6.23	-12.98	-7.2	-13.16	-15.48	-4.13	-3.54	-1.41	1.37
EV/EBITDA High	- -	0.81	-1.63	-13.31	-10.4	-18.27	-10.37	-42.32	-34.99	-8.31	-5.02	-3.68	1.37
EV/EBITDA Low	- -	0.81	-1.63	-2.71	-3.61	-6.66	-5.36	-5.41	-8.59	-2.12	-2.3	- -	1.37
EV/EBIT Average	- -	0.8	-1.61	-6.42	-6.09	-12.61	-7.06	-12.77	-15.08	-4.01	-3.41	-1.38	1.29
EV/EBIT High	- -	0.8	-1.61	-13.14	-10.16	-17.74	-10.16	-41.08	-34.07	-8.07	-4.84	-3.59	1.29
EV/EBIT Low	- -	0.8	-1.61	-2.68	-3.53	-6.47	-5.26	-5.25	-8.36	-2.06	-2.22	- -	1.29
Last Price	- -	- -	- -	16.23	30.73	22.75	29.61	70.11	26.55	8.87	10.13	1.27	2.05
High Price	- -	- -	- -	43.99	32.85	45.02	32.82	96.45	99.95	27.99	11.93	11.58	4.54
Enterprise Value Average	- -	-10	57	624	731	1,434	994	1,722	2,912	907	577	330	-129
Enterprise Value High	- -	-10	57	1,277	1,219	2,018	1,431	5,539	6,581	1,824	819	857	-129
Enterprise Value Low	- -	-10	57	260	423	736	741	708	1,615	466	375	-1	-129

	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
Shares Outstanding	36	36	36	36	45	49	54	63	68	69	82	83	98
Diluted Weighted Avg Shares	- -	15	36	32	40	47	50	59	68	69	76	82	- -
Basic Weighted Avg Shares	- -	15	36	32	40	47	50	59	68	69	76	82	- -
Revenue per Share	- -	- -	0.05	0.19	0.34	0.68	0.41	1.55	0.38	0.29	1.03	0.39	- -
EBITDA per Share	- -	-0.81	-0.98	-2.98	-2.91	-2.35	-2.76	-2.23	-2.78	-3.2	-2.15	-2.83	- -
Operating Income per Share	- -	-0.82	-0.99	-3.02	-2.97	-2.41	-2.82	-2.3	-2.86	-3.29	-2.23	-2.9	- -
Basic EPS, GAAP	- -	-0.83	-2.05	-3.02	-2.98	-2.33	-2.68	-1.98	-2.85	-3.21	-2.02	-2.88	- -
Basic EPS from Cont Ops	- -	-0.89	-2.04	-3.02	-2.98	-2.33	-2.68	-1.98	-2.85	-3.21	-2.02	-2.88	- -
Diluted EPS, GAAP	- -	-0.83	-2.05	-3.02	-2.98	-2.33	-2.68	-1.98	-2.85	-3.21	-2.02	-2.88	- -
Diluted EPS from Cont Ops	- -	-0.89	-2.04	-3.02	-2.98	-2.33	-2.68	-1.98	-2.85	-3.21	-2.02	-2.88	- -
Dividend per Share	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Cash Flow per Share	- -	-0.56	-0.15	-1.56	-0.23	-0.97	-0.81	-3.07	-2.42	-2.58	-1.74	-2.55	- -
Free Cash Flow per Basic Share	- -	-0.64	-0.19	-1.67	-0.28	-1.07	-0.94	-3.19	-2.54	-2.64	-1.8	-2.66	- -
Cash & Equivalents per Share	- -	0.69	4.01	5.75	8.16	7.83	9.15	6.86	7.39	5.01	4.25	3.28	- -
Book Value per Share	- -	-1	-2.47	-5.76	-7.58	-8.84	-10.99	-11.35	-12.68	-15.7	-16.21	-17.83	- -
Tangible Book Value per Share	- -	-0.99	-2.33	4.18	5.16	5.01	5.25	6.72	8.19	5.25	4.6	1.63	- -

Editas Medicine, Inc.

Profitability (USD)

Credit (USD)

Liquidity (USD)

Working Capital (USD)

Enterprise Value (USD)

Multiples (USD)

Per Share Data Items (USD)